unresectable digestive malignancies
Conditions
Interventions
None listed
Sponsors
Hokkaido university hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Over 18 years of age 2. Presence of unresectable gastrointestinal malignancies 3. Written informed consent
Exclusion criteria
Exclusion criteria: 1. History of hypersensitivity to inulin. 2. Those who are taking probucol, tocopherol acetate, or vitamin preparations and are unable to take a break from taking them on the day before and on the day of inulin clearance measurement. 3. The patient is taking methyldopa orally. 4. eGFR calculated using the Japanese Society of Nephrology's estimation formula is less than 15 mL/min/1.73m2. 5. Subjects who are taking steroids and cannot stop taking them for 14 days before measuring inulin clearance. 6. Other individuals who are judged by the research director or co-researcher to be inappropriate as research subjects.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Correlation between inulin clearance and eGFR calculated using various estimation equations | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical characteristics of cases with significant discrepancies between inulin clearance and eCcr calculated by the CG equation | — |
Countries
Japan
Contacts
Public ContactShiho Kaneko
Hokkaido University Hospital Division of Cancer Center
Outcome results
None listed